NASDAQ: ORGOOrganogenesis Holdings Inc Stock Ownership - Who owns Organogenesis Holdings?
Insider buying vs selling
Have Organogenesis Holdings Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Glenn H. Nussdorf | Director | 2025-11-26 | 187,957 | $5.29 | $994.29kSell |
| Glenn H. Nussdorf | Director | 2025-11-25 | 12,043 | $5.30 | $63.83kSell |
| Glenn H. Nussdorf | Director | 2025-11-24 | 100,000 | $5.34 | $534.00kSell |
| Brian Grow | Chief Commercial Officer | 2025-08-11 | 4,060 | $2.47 | $10.03kBuy |
| Brian Grow | Chief Commercial Officer | 2025-08-11 | 2,173 | $4.62 | $10.03kSell |
| Robert Cavorsi | Vice President Strategy | 2025-07-16 | 360 | $4.47 | $1.61kSell |
| Glenn H. Nussdorf | Director | 2025-06-10 | 18,620 | $3.56 | $66.25kSell |
| Glenn H. Nussdorf | Director | 2025-06-09 | 4,156 | $3.50 | $14.55kSell |
| Lori Freedman | Chief Admin. and Legal Officer | 2025-06-06 | 9,022 | $2.99 | $26.95kBuy |
| Lori Freedman | Chief Admin. and Legal Officer | 2025-06-05 | 142,379 | $2.91 | $413.61kBuy |
ORGO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when ORGO insiders and whales buy or sell their stock.
ORGO Shareholders
What type of owners hold Organogenesis Holdings Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Alan A. Ades | 134.71% | 170,965,780 | $808.67M | Insider |
| Dennis Erani | 96.29% | 122,207,338 | $578.04M | Insider |
| Red Holdings LLC | 93.68% | 118,896,054 | $562.38M | Insider |
| Erani 2012 Issue Trust Dated 12 Dennis | 93.68% | 118,896,054 | $562.38M | Insider |
| Erani Family Trust Dated 12 Albert | 93.68% | 118,896,054 | $562.38M | Insider |
| Glenn H. Nussdorf | 63.62% | 80,743,536 | $381.92M | Insider |
| 2016 Organo 10year Grat Ua Gn | 46.84% | 59,448,027 | $281.19M | Insider |
| Albert Erani | 40.65% | 51,585,403 | $244.00M | Insider |
| 2016 Family Trust Uad August 12 2016 Gn | 40.25% | 51,085,403 | $241.63M | Insider |
| David F. Burgstahler | 12.26% | 15,561,473 | $73.61M | Insider |
ORGO vs Pharmaceutical Stocks
Organogenesis Holdings Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.